It was also reported that glycine-β-muricholic acid (Gly-MCA) inhibited FXR signaling exclusively in intestine, resulting in the decrease of serum and intestine ceramide level and the improvement of metabolic dysfunction in obesity mouse (Jiang et al., 2015b). The gene discussed is NR1H4; the disease is Obesity.